The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty

PURPOSE: The effects of gonadotropin-releasing hormone agonist (GnRHa) treatment on body mass index (BMI) are controversial in girls with central precocious puberty (CPP). We therefore evaluated auxological parameters during GnRHa therapy in patients with CPP, specifically focusing on changes in BMI...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Won Jun, Ko, Keun Hyeok, Lee, Kon Hee, Hwang, Il Tae, Oh, Yeon Joung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Endocrinology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401822/
https://www.ncbi.nlm.nih.gov/pubmed/28443259
http://dx.doi.org/10.6065/apem.2017.22.1.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401822/
https://www.ncbi.nlm.nih.gov/pubmed/28443259
http://dx.doi.org/10.6065/apem.2017.22.1.49

Ejemplares similares